nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ABCB1—ovarian cancer	0.359	1	CbGaD
Alfentanil—CYP3A7—Paclitaxel—ovarian cancer	0.0562	0.109	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0562	0.109	CbGbCtD
Alfentanil—ABCB1—Topotecan—ovarian cancer	0.0554	0.107	CbGbCtD
Alfentanil—CYP3A5—Paclitaxel—ovarian cancer	0.0422	0.0816	CbGbCtD
Alfentanil—CYP3A7—Docetaxel—ovarian cancer	0.0406	0.0787	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0406	0.0787	CbGbCtD
Alfentanil—ABCB1—Vinorelbine—ovarian cancer	0.0391	0.0756	CbGbCtD
Alfentanil—CYP3A4—Topotecan—ovarian cancer	0.0332	0.0643	CbGbCtD
Alfentanil—CYP3A5—Docetaxel—ovarian cancer	0.0305	0.059	CbGbCtD
Alfentanil—ABCB1—Paclitaxel—ovarian cancer	0.0274	0.0531	CbGbCtD
Alfentanil—CYP3A4—Vinorelbine—ovarian cancer	0.0234	0.0453	CbGbCtD
Alfentanil—ABCB1—Docetaxel—ovarian cancer	0.0198	0.0384	CbGbCtD
Alfentanil—CYP3A4—Paclitaxel—ovarian cancer	0.0164	0.0318	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—ovarian cancer	0.0148	0.0286	CbGbCtD
Alfentanil—CYP3A4—Docetaxel—ovarian cancer	0.0119	0.023	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—ovarian cancer	0.00886	0.0172	CbGbCtD
Alfentanil—Injection site pain—Doxorubicin—ovarian cancer	0.000568	0.00459	CcSEcCtD
Alfentanil—Convulsion—Melphalan—ovarian cancer	0.000565	0.00457	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000563	0.00455	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000552	0.00446	CcSEcCtD
Alfentanil—Anaphylactic shock—Topotecan—ovarian cancer	0.000544	0.0044	CcSEcCtD
Alfentanil—Dyskinesia—Epirubicin—ovarian cancer	0.000533	0.00431	CcSEcCtD
Alfentanil—Nervous system disorder—Topotecan—ovarian cancer	0.000533	0.00431	CcSEcCtD
Alfentanil—Anaphylactic shock—Melphalan—ovarian cancer	0.000532	0.0043	CcSEcCtD
Alfentanil—Skin disorder—Topotecan—ovarian cancer	0.000528	0.00427	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000527	0.00426	CcSEcCtD
Alfentanil—Fatigue—Chlorambucil—ovarian cancer	0.000527	0.00426	CcSEcCtD
Alfentanil—Hyperhidrosis—Topotecan—ovarian cancer	0.000526	0.00425	CcSEcCtD
Alfentanil—Pain—Chlorambucil—ovarian cancer	0.000522	0.00422	CcSEcCtD
Alfentanil—Tachycardia—Melphalan—ovarian cancer	0.00052	0.0042	CcSEcCtD
Alfentanil—Skin disorder—Melphalan—ovarian cancer	0.000517	0.00418	CcSEcCtD
Alfentanil—Feeling abnormal—Chlorambucil—ovarian cancer	0.000503	0.00407	CcSEcCtD
Alfentanil—Hiccups—Epirubicin—ovarian cancer	0.000501	0.00405	CcSEcCtD
Alfentanil—Hypotension—Melphalan—ovarian cancer	0.000497	0.00402	CcSEcCtD
Alfentanil—Cough—Vinorelbine—ovarian cancer	0.000497	0.00402	CcSEcCtD
Alfentanil—Dyskinesia—Doxorubicin—ovarian cancer	0.000494	0.00399	CcSEcCtD
Alfentanil—Hypertension—Vinorelbine—ovarian cancer	0.000492	0.00398	CcSEcCtD
Alfentanil—Urticaria—Chlorambucil—ovarian cancer	0.000485	0.00392	CcSEcCtD
Alfentanil—Body temperature increased—Chlorambucil—ovarian cancer	0.000483	0.0039	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000482	0.0039	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000469	0.00379	CcSEcCtD
Alfentanil—Fatigue—Topotecan—ovarian cancer	0.000469	0.00379	CcSEcCtD
Alfentanil—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000465	0.00376	CcSEcCtD
Alfentanil—Pain—Topotecan—ovarian cancer	0.000465	0.00376	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—ovarian cancer	0.000464	0.00375	CcSEcCtD
Alfentanil—Epistaxis—Paclitaxel—ovarian cancer	0.000463	0.00374	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00046	0.00372	CcSEcCtD
Alfentanil—Fatigue—Melphalan—ovarian cancer	0.000459	0.00371	CcSEcCtD
Alfentanil—Bronchospasm—Docetaxel—ovarian cancer	0.000459	0.00371	CcSEcCtD
Alfentanil—Nervous system disorder—Vinorelbine—ovarian cancer	0.000456	0.00369	CcSEcCtD
Alfentanil—Pain—Melphalan—ovarian cancer	0.000455	0.00368	CcSEcCtD
Alfentanil—Tachycardia—Vinorelbine—ovarian cancer	0.000454	0.00367	CcSEcCtD
Alfentanil—Skin disorder—Vinorelbine—ovarian cancer	0.000452	0.00365	CcSEcCtD
Alfentanil—Hypersensitivity—Chlorambucil—ovarian cancer	0.00045	0.00364	CcSEcCtD
Alfentanil—Bradycardia—Paclitaxel—ovarian cancer	0.000448	0.00362	CcSEcCtD
Alfentanil—Feeling abnormal—Topotecan—ovarian cancer	0.000448	0.00362	CcSEcCtD
Alfentanil—Asthenia—Chlorambucil—ovarian cancer	0.000438	0.00354	CcSEcCtD
Alfentanil—Hypotension—Vinorelbine—ovarian cancer	0.000435	0.00351	CcSEcCtD
Alfentanil—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000433	0.0035	CcSEcCtD
Alfentanil—Pruritus—Chlorambucil—ovarian cancer	0.000432	0.00349	CcSEcCtD
Alfentanil—Urticaria—Topotecan—ovarian cancer	0.000432	0.00349	CcSEcCtD
Alfentanil—Body temperature increased—Topotecan—ovarian cancer	0.00043	0.00347	CcSEcCtD
Alfentanil—Visual impairment—Paclitaxel—ovarian cancer	0.000424	0.00343	CcSEcCtD
Alfentanil—Urticaria—Melphalan—ovarian cancer	0.000423	0.00342	CcSEcCtD
Alfentanil—Eye disorder—Paclitaxel—ovarian cancer	0.000412	0.00333	CcSEcCtD
Alfentanil—Cardiac disorder—Paclitaxel—ovarian cancer	0.000409	0.0033	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000402	0.00325	CcSEcCtD
Alfentanil—Fatigue—Vinorelbine—ovarian cancer	0.000401	0.00324	CcSEcCtD
Alfentanil—Hypersensitivity—Topotecan—ovarian cancer	0.000401	0.00324	CcSEcCtD
Alfentanil—Angiopathy—Paclitaxel—ovarian cancer	0.0004	0.00323	CcSEcCtD
Alfentanil—Pain—Vinorelbine—ovarian cancer	0.000398	0.00322	CcSEcCtD
Alfentanil—Immune system disorder—Paclitaxel—ovarian cancer	0.000398	0.00322	CcSEcCtD
Alfentanil—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000397	0.00321	CcSEcCtD
Alfentanil—Chills—Paclitaxel—ovarian cancer	0.000395	0.00319	CcSEcCtD
Alfentanil—Arrhythmia—Paclitaxel—ovarian cancer	0.000393	0.00318	CcSEcCtD
Alfentanil—Hypersensitivity—Melphalan—ovarian cancer	0.000392	0.00317	CcSEcCtD
Alfentanil—Epistaxis—Docetaxel—ovarian cancer	0.000392	0.00317	CcSEcCtD
Alfentanil—Asthenia—Topotecan—ovarian cancer	0.00039	0.00315	CcSEcCtD
Alfentanil—Vomiting—Chlorambucil—ovarian cancer	0.000388	0.00314	CcSEcCtD
Alfentanil—Mental disorder—Paclitaxel—ovarian cancer	0.000386	0.00312	CcSEcCtD
Alfentanil—Pruritus—Topotecan—ovarian cancer	0.000385	0.00311	CcSEcCtD
Alfentanil—Erythema—Paclitaxel—ovarian cancer	0.000383	0.0031	CcSEcCtD
Alfentanil—Feeling abnormal—Vinorelbine—ovarian cancer	0.000383	0.0031	CcSEcCtD
Alfentanil—Asthenia—Melphalan—ovarian cancer	0.000382	0.00309	CcSEcCtD
Alfentanil—Pruritus—Melphalan—ovarian cancer	0.000377	0.00305	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000376	0.00304	CcSEcCtD
Alfentanil—Urticaria—Vinorelbine—ovarian cancer	0.00037	0.00299	CcSEcCtD
Alfentanil—Body temperature increased—Vinorelbine—ovarian cancer	0.000368	0.00297	CcSEcCtD
Alfentanil—Connective tissue disorder—Docetaxel—ovarian cancer	0.000367	0.00297	CcSEcCtD
Alfentanil—Nausea—Chlorambucil—ovarian cancer	0.000363	0.00293	CcSEcCtD
Alfentanil—Vision blurred—Paclitaxel—ovarian cancer	0.000361	0.00292	CcSEcCtD
Alfentanil—Visual impairment—Docetaxel—ovarian cancer	0.00036	0.00291	CcSEcCtD
Alfentanil—Dizziness—Topotecan—ovarian cancer	0.00036	0.00291	CcSEcCtD
Alfentanil—Agitation—Paclitaxel—ovarian cancer	0.000352	0.00285	CcSEcCtD
Alfentanil—Eye disorder—Docetaxel—ovarian cancer	0.000349	0.00282	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000348	0.00281	CcSEcCtD
Alfentanil—Cardiac disorder—Docetaxel—ovarian cancer	0.000346	0.0028	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—ovarian cancer	0.000346	0.0028	CcSEcCtD
Alfentanil—Vomiting—Topotecan—ovarian cancer	0.000346	0.00279	CcSEcCtD
Alfentanil—Rash—Topotecan—ovarian cancer	0.000343	0.00277	CcSEcCtD
Alfentanil—Hypersensitivity—Vinorelbine—ovarian cancer	0.000343	0.00277	CcSEcCtD
Alfentanil—Dermatitis—Topotecan—ovarian cancer	0.000343	0.00277	CcSEcCtD
Alfentanil—Headache—Topotecan—ovarian cancer	0.000341	0.00275	CcSEcCtD
Alfentanil—Angiopathy—Docetaxel—ovarian cancer	0.000339	0.00274	CcSEcCtD
Alfentanil—Vomiting—Melphalan—ovarian cancer	0.000339	0.00274	CcSEcCtD
Alfentanil—Immune system disorder—Docetaxel—ovarian cancer	0.000337	0.00273	CcSEcCtD
Alfentanil—Loss of consciousness—Paclitaxel—ovarian cancer	0.000337	0.00272	CcSEcCtD
Alfentanil—Mediastinal disorder—Docetaxel—ovarian cancer	0.000336	0.00272	CcSEcCtD
Alfentanil—Rash—Melphalan—ovarian cancer	0.000336	0.00271	CcSEcCtD
Alfentanil—Dermatitis—Melphalan—ovarian cancer	0.000335	0.00271	CcSEcCtD
Alfentanil—Chills—Docetaxel—ovarian cancer	0.000335	0.00271	CcSEcCtD
Alfentanil—Cough—Paclitaxel—ovarian cancer	0.000335	0.0027	CcSEcCtD
Alfentanil—Asthenia—Vinorelbine—ovarian cancer	0.000334	0.0027	CcSEcCtD
Alfentanil—Arrhythmia—Docetaxel—ovarian cancer	0.000333	0.0027	CcSEcCtD
Alfentanil—Convulsion—Paclitaxel—ovarian cancer	0.000332	0.00268	CcSEcCtD
Alfentanil—Hypertension—Paclitaxel—ovarian cancer	0.000331	0.00268	CcSEcCtD
Alfentanil—Pruritus—Vinorelbine—ovarian cancer	0.000329	0.00266	CcSEcCtD
Alfentanil—Mental disorder—Docetaxel—ovarian cancer	0.000327	0.00264	CcSEcCtD
Alfentanil—Erythema—Docetaxel—ovarian cancer	0.000325	0.00263	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000324	0.00262	CcSEcCtD
Alfentanil—Nausea—Topotecan—ovarian cancer	0.000323	0.00261	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—ovarian cancer	0.00032	0.00259	CcSEcCtD
Alfentanil—Nausea—Melphalan—ovarian cancer	0.000316	0.00256	CcSEcCtD
Alfentanil—Confusional state—Paclitaxel—ovarian cancer	0.000315	0.00255	CcSEcCtD
Alfentanil—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000313	0.00253	CcSEcCtD
Alfentanil—Dizziness—Vinorelbine—ovarian cancer	0.000308	0.00249	CcSEcCtD
Alfentanil—Nervous system disorder—Paclitaxel—ovarian cancer	0.000307	0.00248	CcSEcCtD
Alfentanil—Tachycardia—Paclitaxel—ovarian cancer	0.000305	0.00247	CcSEcCtD
Alfentanil—Skin disorder—Paclitaxel—ovarian cancer	0.000304	0.00246	CcSEcCtD
Alfentanil—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000302	0.00244	CcSEcCtD
Alfentanil—Vomiting—Vinorelbine—ovarian cancer	0.000296	0.00239	CcSEcCtD
Alfentanil—Rash—Vinorelbine—ovarian cancer	0.000293	0.00237	CcSEcCtD
Alfentanil—Dermatitis—Vinorelbine—ovarian cancer	0.000293	0.00237	CcSEcCtD
Alfentanil—Hypotension—Paclitaxel—ovarian cancer	0.000292	0.00236	CcSEcCtD
Alfentanil—Headache—Vinorelbine—ovarian cancer	0.000291	0.00236	CcSEcCtD
Alfentanil—Loss of consciousness—Docetaxel—ovarian cancer	0.000286	0.00231	CcSEcCtD
Alfentanil—Cough—Docetaxel—ovarian cancer	0.000284	0.00229	CcSEcCtD
Alfentanil—Convulsion—Docetaxel—ovarian cancer	0.000282	0.00228	CcSEcCtD
Alfentanil—Hypertension—Docetaxel—ovarian cancer	0.000281	0.00227	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—ovarian cancer	0.00028	0.00227	CcSEcCtD
Alfentanil—Somnolence—Paclitaxel—ovarian cancer	0.000278	0.00225	CcSEcCtD
Alfentanil—Nausea—Vinorelbine—ovarian cancer	0.000276	0.00223	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000275	0.00222	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00027	0.00218	CcSEcCtD
Alfentanil—Fatigue—Paclitaxel—ovarian cancer	0.00027	0.00218	CcSEcCtD
Alfentanil—Pain—Paclitaxel—ovarian cancer	0.000268	0.00216	CcSEcCtD
Alfentanil—Confusional state—Docetaxel—ovarian cancer	0.000267	0.00216	CcSEcCtD
Alfentanil—Anaphylactic shock—Docetaxel—ovarian cancer	0.000265	0.00214	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—ovarian cancer	0.000265	0.00214	CcSEcCtD
Alfentanil—Nervous system disorder—Docetaxel—ovarian cancer	0.00026	0.0021	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—ovarian cancer	0.000259	0.0021	CcSEcCtD
Alfentanil—Tachycardia—Docetaxel—ovarian cancer	0.000259	0.00209	CcSEcCtD
Alfentanil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000258	0.00208	CcSEcCtD
Alfentanil—Skin disorder—Docetaxel—ovarian cancer	0.000258	0.00208	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—ovarian cancer	0.000256	0.00207	CcSEcCtD
Alfentanil—Urticaria—Paclitaxel—ovarian cancer	0.000249	0.00201	CcSEcCtD
Alfentanil—Hypotension—Docetaxel—ovarian cancer	0.000248	0.002	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—ovarian cancer	0.000247	0.002	CcSEcCtD
Alfentanil—Body temperature increased—Paclitaxel—ovarian cancer	0.000247	0.002	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—ovarian cancer	0.000245	0.00198	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—ovarian cancer	0.000243	0.00196	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—ovarian cancer	0.000237	0.00192	CcSEcCtD
Alfentanil—Somnolence—Docetaxel—ovarian cancer	0.000236	0.00191	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—ovarian cancer	0.000235	0.0019	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—ovarian cancer	0.000234	0.00189	CcSEcCtD
Alfentanil—Hypersensitivity—Paclitaxel—ovarian cancer	0.000231	0.00186	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000229	0.00185	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000229	0.00185	CcSEcCtD
Alfentanil—Fatigue—Docetaxel—ovarian cancer	0.000229	0.00185	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—ovarian cancer	0.000228	0.00185	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—ovarian cancer	0.000227	0.00184	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—ovarian cancer	0.000227	0.00183	CcSEcCtD
Alfentanil—Pain—Docetaxel—ovarian cancer	0.000227	0.00183	CcSEcCtD
Alfentanil—Chills—Epirubicin—ovarian cancer	0.000226	0.00183	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—ovarian cancer	0.000225	0.00182	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—ovarian cancer	0.000224	0.00181	CcSEcCtD
Alfentanil—Asthenia—Paclitaxel—ovarian cancer	0.000224	0.00181	CcSEcCtD
Alfentanil—Pruritus—Paclitaxel—ovarian cancer	0.000221	0.00179	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—ovarian cancer	0.000221	0.00178	CcSEcCtD
Alfentanil—Erythema—Epirubicin—ovarian cancer	0.000219	0.00177	CcSEcCtD
Alfentanil—Feeling abnormal—Docetaxel—ovarian cancer	0.000219	0.00177	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—ovarian cancer	0.000218	0.00176	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—ovarian cancer	0.000216	0.00175	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—ovarian cancer	0.000211	0.00171	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—ovarian cancer	0.00021	0.0017	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00021	0.0017	CcSEcCtD
Alfentanil—Body temperature increased—Docetaxel—ovarian cancer	0.00021	0.00169	CcSEcCtD
Alfentanil—Chills—Doxorubicin—ovarian cancer	0.000209	0.00169	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—ovarian cancer	0.000208	0.00168	CcSEcCtD
Alfentanil—Dizziness—Paclitaxel—ovarian cancer	0.000207	0.00167	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—ovarian cancer	0.000207	0.00167	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—ovarian cancer	0.000204	0.00165	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—ovarian cancer	0.000203	0.00164	CcSEcCtD
Alfentanil—Agitation—Epirubicin—ovarian cancer	0.000201	0.00163	CcSEcCtD
Alfentanil—Vomiting—Paclitaxel—ovarian cancer	0.000199	0.00161	CcSEcCtD
Alfentanil—Rash—Paclitaxel—ovarian cancer	0.000197	0.00159	CcSEcCtD
Alfentanil—Dermatitis—Paclitaxel—ovarian cancer	0.000197	0.00159	CcSEcCtD
Alfentanil—Headache—Paclitaxel—ovarian cancer	0.000196	0.00158	CcSEcCtD
Alfentanil—Hypersensitivity—Docetaxel—ovarian cancer	0.000195	0.00158	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—ovarian cancer	0.000193	0.00156	CcSEcCtD
Alfentanil—Cough—Epirubicin—ovarian cancer	0.000191	0.00155	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—ovarian cancer	0.000191	0.00154	CcSEcCtD
Alfentanil—Asthenia—Docetaxel—ovarian cancer	0.00019	0.00154	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—ovarian cancer	0.00019	0.00154	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—ovarian cancer	0.000189	0.00153	CcSEcCtD
Alfentanil—Pruritus—Docetaxel—ovarian cancer	0.000188	0.00152	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—ovarian cancer	0.000186	0.00151	CcSEcCtD
Alfentanil—Nausea—Paclitaxel—ovarian cancer	0.000186	0.0015	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000185	0.0015	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—ovarian cancer	0.00018	0.00146	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—ovarian cancer	0.000179	0.00145	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000178	0.00144	CcSEcCtD
Alfentanil—Cough—Doxorubicin—ovarian cancer	0.000177	0.00143	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—ovarian cancer	0.000176	0.00142	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—ovarian cancer	0.000175	0.00142	CcSEcCtD
Alfentanil—Dizziness—Docetaxel—ovarian cancer	0.000175	0.00142	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—ovarian cancer	0.000175	0.00142	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—ovarian cancer	0.000175	0.00141	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—ovarian cancer	0.000174	0.0014	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—ovarian cancer	0.000173	0.0014	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000171	0.00139	CcSEcCtD
Alfentanil—Vomiting—Docetaxel—ovarian cancer	0.000169	0.00136	CcSEcCtD
Alfentanil—Rash—Docetaxel—ovarian cancer	0.000167	0.00135	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—ovarian cancer	0.000167	0.00135	CcSEcCtD
Alfentanil—Dermatitis—Docetaxel—ovarian cancer	0.000167	0.00135	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—ovarian cancer	0.000167	0.00135	CcSEcCtD
Alfentanil—Headache—Docetaxel—ovarian cancer	0.000166	0.00134	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000165	0.00134	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000162	0.00131	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—ovarian cancer	0.000162	0.00131	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—ovarian cancer	0.000161	0.0013	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00016	0.00129	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—ovarian cancer	0.000159	0.00129	CcSEcCtD
Alfentanil—Nausea—Docetaxel—ovarian cancer	0.000158	0.00127	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—ovarian cancer	0.000155	0.00125	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000154	0.00125	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—ovarian cancer	0.000154	0.00125	CcSEcCtD
Alfentanil—Pain—Epirubicin—ovarian cancer	0.000153	0.00124	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—ovarian cancer	0.000147	0.00119	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—ovarian cancer	0.000147	0.00119	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000143	0.00116	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—ovarian cancer	0.000143	0.00115	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—ovarian cancer	0.000142	0.00115	CcSEcCtD
Alfentanil—Pain—Doxorubicin—ovarian cancer	0.000142	0.00114	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—ovarian cancer	0.000141	0.00114	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—ovarian cancer	0.000136	0.0011	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—ovarian cancer	0.000132	0.00107	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—ovarian cancer	0.000131	0.00106	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—ovarian cancer	0.000131	0.00106	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—ovarian cancer	0.000128	0.00104	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—ovarian cancer	0.000127	0.00102	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—ovarian cancer	0.000122	0.000986	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—ovarian cancer	0.000119	0.00096	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—ovarian cancer	0.000118	0.000956	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—ovarian cancer	0.000117	0.000947	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—ovarian cancer	0.000114	0.000919	CcSEcCtD
Alfentanil—Rash—Epirubicin—ovarian cancer	0.000113	0.000912	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—ovarian cancer	0.000113	0.000911	CcSEcCtD
Alfentanil—Headache—Epirubicin—ovarian cancer	0.000112	0.000906	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—ovarian cancer	0.000109	0.000885	CcSEcCtD
Alfentanil—Nausea—Epirubicin—ovarian cancer	0.000106	0.000859	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—ovarian cancer	0.000105	0.000851	CcSEcCtD
Alfentanil—Rash—Doxorubicin—ovarian cancer	0.000104	0.000844	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—ovarian cancer	0.000104	0.000843	CcSEcCtD
Alfentanil—Headache—Doxorubicin—ovarian cancer	0.000104	0.000838	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—ovarian cancer	9.83e-05	0.000795	CcSEcCtD
